These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 15100364

  • 1. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
    Zhao X, Yamamoto T, Newman JW, Kim IH, Watanabe T, Hammock BD, Stewart J, Pollock JS, Pollock DM, Imig JD.
    J Am Soc Nephrol; 2004 May; 15(5):1244-53. PubMed ID: 15100364
    [Abstract] [Full Text] [Related]

  • 2. Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats.
    Ghosh S, Chiang PC, Wahlstrom JL, Fujiwara H, Selbo JG, Roberds SL.
    Basic Clin Pharmacol Toxicol; 2008 May; 102(5):453-8. PubMed ID: 18312493
    [Abstract] [Full Text] [Related]

  • 3. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.
    Imig JD, Zhao X, Capdevila JH, Morisseau C, Hammock BD.
    Hypertension; 2002 Feb; 39(2 Pt 2):690-4. PubMed ID: 11882632
    [Abstract] [Full Text] [Related]

  • 4. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
    Sharkey LC, Radin MJ, Heller L, Rogers LK, Tobias A, Matise I, Wang Q, Apple FS, McCune SA.
    Toxicol Appl Pharmacol; 2013 Nov 15; 273(1):47-57. PubMed ID: 23993975
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Červenka L, Melenovský V, Husková Z, Škaroupková P, Nishiyama A, Sadowski J.
    Clin Exp Pharmacol Physiol; 2015 Jul 15; 42(7):795-807. PubMed ID: 25969338
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.
    Imig JD.
    Cardiovasc Drug Rev; 2006 Jul 15; 24(2):169-88. PubMed ID: 16961727
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
    Imig JD, Zhao X, Zaharis CZ, Olearczyk JJ, Pollock DM, Newman JW, Kim IH, Watanabe T, Hammock BD.
    Hypertension; 2005 Oct 15; 46(4):975-81. PubMed ID: 16157792
    [Abstract] [Full Text] [Related]

  • 14. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
    Gauthier KM, Olson L, Harder A, Isbell M, Imig JD, Gutterman DD, Falck JR, Campbell WB.
    Am J Physiol Renal Physiol; 2011 Oct 15; 301(4):F765-72. PubMed ID: 21753077
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition.
    Davis BB, Morisseau C, Newman JW, Pedersen TL, Hammock BD, Weiss RH.
    J Pharmacol Exp Ther; 2006 Feb 15; 316(2):815-21. PubMed ID: 16221742
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
    Katary MM, Pye C, Elmarakby AA.
    Prostaglandins Other Lipid Mediat; 2017 Sep 15; 132():3-11. PubMed ID: 27596333
    [Abstract] [Full Text] [Related]

  • 19. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
    Eldrup AB, Soleymanzadeh F, Farrow NA, Kukulka A, De Lombaert S.
    Bioorg Med Chem Lett; 2010 Jan 15; 20(2):571-5. PubMed ID: 19969453
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.